Improving Outcomes After AF Ablation in Obese Patients

Recruiting N/A Interventional Study
Atrial Fibrillation (AF) Obesity (Disorder)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
20 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
520 (estimated)
Sponsor
National Taiwan University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Improving Outcomes After AF Ablation in Obese Patients

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with Class I indication of catheter ablation of paroxysmal or persistent AF and will undergo catheter ablation at National Taiwan University Hospital. Exclusion Criteria: 1. Informed consent could not be obtained due to personal problem 2. Unwillingness or inability…
Contacts

Yen Bin, Liu Associate Professor of Medicine, MD, PhD

+886-0972651035

yenbin@ntu.edu.tw

CONTACT

Chun Kai, Chen Visiting staff, MD

+886-0921915778

neochen@ntuh.gov.tw

CONTACT